Seller record · Telehealth service

TrueMe

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S2, prescription gating: Each product page states that no intake form is required before paying, and its start button adds the plan to a cart. The answers list choosing a plan and completing checkout before the medical intake, with a refund if the provider does not approve treatment. 2 more criteria also fail; see the table below.

At a glance

TrueMeTelehealth service

5/8criteria passed
Price
Compounded semaglutide $139 a month, or $89 a month on a 3-month plan paid at once ($267)
Sells
compounded semaglutide, compounded tirzepatide, NAD+, and 1 more
FDA letters
None on file
Visit TrueMeSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth platform selling compounded semaglutide and tirzepatide, NAD+ and sermorelin at one price for any dose in six states, with care from independent providers. The buyer checks out before the medical intake, and a named compounding pharmacy in Texas fills the prescriptions.

Operating entity TRUEMEHEALTH LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSTrueMe's FAQ
S2Prescription gatingFAILTrueMe's GLP-1 page; TrueMe's GLP-1 GIP page; TrueMe's FAQ
S3Pharmacy identificationPASSTrueMe's FAQ; TrueMe's returns refund policy
S4Compounding disclosurePASSTrueMe's GLP-1 page; TrueMe's FAQ
S5Analytical documentationFAILTrueMe's GLP-1 page; TrueMe's FAQ; TrueMe's returns refund policy
S6Business addressFAILTrueMe's contact page; TrueMe's privacy policy; TrueMe's returns refund policy
S7Price disclosurePASSTrueMe's GLP-1 page; TrueMe's GLP-1 GIP page; TrueMe's sermorelin page; TrueMe's website
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSAn independent licensed provider reviews each medical intake and decides whether treatment is medically appropriate, and renewals also need provider approval. No provider is named.Source: TrueMe's FAQ.
S2FAILEach product page states that no intake form is required before paying, and its start button adds the plan to a cart. The answers list choosing a plan and completing checkout before the medical intake, with a refund if the provider does not approve treatment.Source: TrueMe's GLP-1 page; TrueMe's GLP-1 GIP page; TrueMe's FAQ.
S3PASSThe answers name the pharmacy that prepares, dispenses and ships every prescription: CarePoint Infusion Pharmacy, a licensed 503A compounding pharmacy, and the returns policy gives its address as 4732 Sugar Grove Blvd, Stafford, Texas.Source: TrueMe's FAQ; TrueMe's returns refund policy.
S4PASSThe product pages and footer state that the medication is compounded and that compounded medications are not FDA-approved or evaluated by the FDA, and the answers repeat it.Source: TrueMe's GLP-1 page; TrueMe's FAQ.
S5FAILNo certificate of analysis or lot document is published on the product pages, in the answers or in the returns policy.Source: TrueMe's GLP-1 page; TrueMe's FAQ; TrueMe's returns refund policy.
S6FAILNo address is printed for the company itself, which the contact page names only as TRUEMEHEALTH LLC. The privacy policy gives two different addresses in care of administrators, 1275 E Baseline Rd #104, Gilbert, AZ 85233 and 4732 Sugar Grove Blvd, Suite 101, Stafford, TX 77477, and the returns policy gives the second as the pharmacy's.Source: TrueMe's contact page; TrueMe's privacy policy; TrueMe's returns refund policy.
S7PASSEach product carries one price for any dose, with the consultation, medication, shipping and supplies included: compounded semaglutide $139 a month month to month or $89 a month on a 3-month plan paid at once ($267), compounded tirzepatide $149 or $99 ($297), and NAD+ and sermorelin $129 or $79 ($237).Source: TrueMe's GLP-1 page; TrueMe's GLP-1 GIP page; TrueMe's sermorelin page; TrueMe's website.
S8PASSNo FDA warning letter names TrueMe or TRUEMEHEALTH LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, NAD+, sermorelin.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+

Visit TrueMe

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.